Get the Stockscreener App
6.14
2.85%
-0.18
Burning Rock Biotech Ltd Adr stock is traded at $6.14, with a volume of 6,877.
It is down -2.85% in the last 24 hours and down -13.03% over the past month.
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
See More
Previous Close:
$6.32
Open:
$6.21
24h Volume:
6,877
Relative Volume:
0.54
Market Cap:
$64.84M
Revenue:
$71.19M
Net Income/Loss:
$-59.54M
P/E Ratio:
-1.0574
EPS:
-5.8068
Net Cash Flow:
$-18.58M
1W Performance:
-8.08%
1M Performance:
-13.03%
6M Performance:
-7.27%
1Y Performance:
-28.05%
1-Day Range:
$6.21
$6.80
1-Week Range:
$6.16
$7.29
52-Week Range:
$2.62
$8.99
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Name
Burning Rock Biotech Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare BNR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
6.27 | 64.84M | 71.19M | -59.54M | -18.58M | -5.8068 |
|
TMO
Thermo Fisher Scientific Inc
|
572.14 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
207.74 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
145.72 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
459.77 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
207.83 | 36.97B | 15.32B | 1.41B | 1.96B | 7.62 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jul-07-20 | Initiated | Cowen | Outperform |
Burning Rock Biotech Ltd Adr Stock (BNR) Latest News
Burning Rock Announces Results of 2024 Annual General Meeting - Marketscreener.com
Burning Rock Announces Results of 2024 Annual General Meeting - GlobeNewswire Inc.
Burning Rock Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Canada Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Burning Rock Biotech CFO Leo Li resigns - Investing.com
Burning Rock Biotech Limited Announces the Resignation of Leo Li as Chief Financial Officer - Marketscreener.com
Brazil Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Making it harder to "buy" China, Inc. - US-China Institute
Transcript : Burning Rock Biotech Limited, Q4 2021 Earnings Call, Mar 22, 2022 - Marketscreener.com
Burning Rock Biotech LtdADR Shares Approach 52-Week LowMarket Mover - Nasdaq
Burning Rock (BNR) in Focus: Stock Moves 5.4% Higher - Yahoo Finance
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Markets Insider
BioLine Rx (NASDAQ:BLRX) Stock Quotes, Forecast and News Summary - Benzinga
Citi Appointed Depositary Bank for Burning Rock Biotech Limited’s Sponsored ADR Program - Business Wire
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO - Benzinga
Burning Rock Biotech Ltd Adr Stock (BNR) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.95%
2.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):